Article
Relevance of PD-L1 Non-Coding Polymorphisms on the Prognosis of a Genetically Admixed…
Pharmacogenomics and Personalized Medicine · 2021 · Machado-Rugolo J, Gutierrez Prieto T, Fabro AT, Parra Cuentas ER, Sá VK, Baldavira CM, Rainho CA, Castelli EC, Farhat C, Takagaki TY, Nagai MA, Capelozzi VL
Key facts
| Title | Relevance of PD-L1 Non-Coding Polymorphisms on the Prognosis of a Genetically Admixed NSCLC Cohort |
|---|---|
| First author | Machado-Rugolo J, Gutierrez Prieto T, Fabro AT, Parra Cuentas ER, Sá VK, Baldavira CM, Rainho CA, Castelli EC, Farhat C, Takagaki TY, Nagai MA, Capelozzi VL |
| Journal | Pharmacogenomics and Personalized Medicine |
| Published | Feb 15, 2021 |
| DOI | 10.2147/PGPM.S286717 |
| Devices mentioned | BK110039, K103302 |
| Product codes mentioned | JJH, NJT, OOI, PFF, PFT, NDS, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1